Visualitza per autor "Ochoa de Olza Amat, Maria"
Ara mostrant els elements 1-3 d 3
-
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Matos Garcia, Ignacio; Hierro Carbó, Cinta; Martín Liberal, Juan Jesús; Berche, Roger; Pedrola Gómez, Anna; Braña Garcia, Irene; Azaro Pedrazzoli, Analía Beatriz; Vieito Villar, Maria; Saavedra Gadea, Omar; Gardeazabal, Itziar; Hernando Calvo, Alberto; Alonso-Casal, Guzman; Galvao De Aquiar, Vladimir; Ochoa de Olza Amat, Maria; Ros Montañá, Fco. Javier; Viaplana Donato, Cristina; Elez Fernandez, Mª Elena; Rodon Ahnert, Jordi; Macarulla Mercadé, Teresa; Oaknin Benzaquen, Ana Mazaltob; Carles Galceran, Joan; Felip Font, Enriqueta; Tabernero Caturla, Josep; Garralda Cabanas, Elena; Villacampa Javierre, Guillermo; Saura Manich, Cristina; Muñoz Couselo, Eva; Dienstmann, Rodrigo (Elsevier, 2021-09) -
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Tan, Daniel S. W.; Martin, Miguel; Ochoa de Olza Amat, Maria; Sarantopoulos, John; Carvajal, Richard; Schoffski, Patrick (BMJ, 2022-02) -
Tumor-Associated Microbiome: Where Do We Stand?
Oliva, Marc; Mulet Margalef, Núria; Ochoa de Olza Amat, Maria; Napoli, Stefania; Mas Lloret, Joan; Laquente, Berta; Nuciforo, Paolo Giovanni (MDPI, 2021-02-01)